🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.

Investigational Drug Gaining Popularity Online

The experimental drug, which remains in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Followers are encouraged to contact these profiles privately for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a flourishing market exists on messaging services, where groups with numerous of participants share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before directing buyers to other platforms for transactions.

Understanding The Experimental Drug

Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The drug affects three intestinal hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies indicate it could assist patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Professionals Express Worries

However, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could result in individuals injecting substances of uncertain source.

Several experts stated the demand for the experimental drug could be linked to the increasing price of licensed slimming treatments such as Mounjaro.

Regulatory Position and Enforcement

Marketing the unapproved drug on TikTok or messaging apps is prohibited in the United Kingdom, as it is an unlicensed medication that cannot be marketed or distributed for personal consumption under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but advertising and supply can still breach medicines, advertising, and consumer regulations, potentially leading to fines, prosecution or imprisonment.

Service Response and Content Removal

Based on the social media company, the platform has taken down violative content and prohibited associated keywords and search suggestions. The company stated it was committed to maintaining the service secure and investing in enhancing compliance measures.

Online Marketplace Activities

Research also found groups with up to 9,000 members selling retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” immediately brings up channels with thousands of members, populated with images of slimming results, positive testimonials and detailed guides for mixing or administering at home.

After minutes of entering one group, a vendor shared WhatsApp details, where the majority of transactions occur. The vendor sent an guidebook and promised delivery within 48 hours. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another provided a image of a alleged laboratory certificate. None inquired about weight, health issues or previous experience.

Product Details and Costs

Within these communities, posts display dark colored parcels with Royal Mail labels, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with sterile water, or ready-to-use injectors usually sold at £160 for 20mg. When asked how long a injector should be used, vendors give contradictory responses ranging from a few weeks to “depends on your body”.

Service Oversight and Safety Actions

A representative for Telegram said it regularly monitored harmful content on its service including material that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they cannot confirm. Although the science behind retatrutide is sound, these digital products may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to current cost increases for authorized weight-loss drugs such as Mounjaro. “With costs increasing, individuals are turning to online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s inside or whether the environment they were produced in was clean,” she explained.

Her team has already seen patients harmed by personal administration from unverified suppliers. “We recognize the disappointment, but purchasing from Telegram or WhatsApp is taking chances with your health,” said Wyllie. “These materials could be impure or improperly measured.”

Producer Position

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority anywhere in the world. “Consequently at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a company investigational substance not yet approved … may expose users to possibly significant health risks”.